基础医学与临床 ›› 2018, Vol. 38 ›› Issue (2): 255-259.

• 短篇综述 • 上一篇    下一篇

骨髓间充质干细胞在骨髓增生异常综合征中的研究进展

庞艳彬1,范丽霞1,罗建民2,杜欣3   

  1. 1. 河北大学附属医院
    2. 河北医科大学第二医院血液内科
    3. 广东省人民医院/广东省医学科学院,华南理工大学医学院 血液内科
  • 收稿日期:2016-12-29 修回日期:2017-03-23 出版日期:2018-02-05 发布日期:2018-01-24
  • 通讯作者: 庞艳彬 E-mail:1113911251@qq.com

Research advances of mesenchymal stem cells from bone marrow in myelodysplastic syndrome

  • Received:2016-12-29 Revised:2017-03-23 Online:2018-02-05 Published:2018-01-24

摘要: 骨髓增生异常综合征(MDS)是以无效造血并伴有向急性髓系白血病(AML)转化的风险为特点的异质性造血系统的恶性肿瘤。骨髓间充质干细胞(MSC)的功能异常在疾病的进展和转化中发挥了重要的作用。与正常MSC相比,MDS患者的MSC在遗传学、表观遗传学、分化和功能等方面均存在差异,而且骨髓活检中MSC密度增加是MDS的不良预后因素, 其支持正常造血的能力下降,有利于克隆细胞生存并向AML转化。对MDS发病机制关键特点加深认识有助于推进产生新的治疗方式。

关键词: 骨髓增生异常综合征, 间充质干细胞, 骨髓微环境, 造血干细胞龛

Abstract: Myelodysplastic syndrome (MDS) comprise a group of clonal hematological malignancies characterized by bone marrow (BM) ineffective hematopoiesis and increased risk for progression to acute myeloid leukemia. The altered BM mesenchymal stem cells (MSC) play a pivotal role in the evolution and propagation of MDS. Compared to normal MSC, MSC in MDS often exhibit altered Cytogenetic, epigenetic, differentiation and functional properties , moreover, high MSC density is associated with poor risk independent of known prognostic factors, which translated into a significantly diminished ability to support normal hematopoiesis, facilitates survival of malignant hematopoietic cells, ultimately promote disease progression and transform to acute myeloid leukemia.Therefore, Characterization of key steps in the pathogenesis of MDS will lead to new approaches to treat patients with this disease.